These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25802141)

  • 1. Minimising menopausal side effects whilst treating endometriosis and fibroids.
    Simpson PD; McLaren JS; Rymer J; Morris EP
    Post Reprod Health; 2015 Mar; 21(1):16-23. PubMed ID: 25802141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey ES
    Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM; Chou CY; Huang SC; Lin HC
    BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
    McLaren JS; Morris E; Rymer J
    Menopause Int; 2012 Jun; 18(2):68-72. PubMed ID: 22611225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):593-5. PubMed ID: 2137979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
    Chwalisz K; Surrey E; Stanczyk FZ
    Reprod Sci; 2012 Jun; 19(6):563-71. PubMed ID: 22457429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues.
    van der Spuy ZM; Wood M; Fieggen G; Hendricks MS
    S Afr Med J; 1993 Jul; 83(7):510-3. PubMed ID: 8211493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Bartels CB; Cayton KC; Chuong FS; Holthouser K; Arian SE; Abraham T; Segars JH
    Clin Obstet Gynecol; 2016 Mar; 59(1):30-52. PubMed ID: 26756261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GnRH analogues for the treatment of fibroids].
    Murillo EO; Cano A
    Med Clin (Barc); 2013 Jul; 141 Suppl 1():35-9. PubMed ID: 24314566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms.
    Adashi EY
    Hum Reprod; 1994 Jul; 9(7):1380-97. PubMed ID: 7962453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levonorgestrel-releasing intrauterine system in modern gynaecology.
    McGavigan CJ; Owen P
    Br J Hosp Med (Lond); 2005 Oct; 66(10):574-7. PubMed ID: 16255257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
    Levy T; Ben-Rafael Z
    Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
    Engel JB; Schally AV
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose add-back therapy during postoperative GnRH agonist treatment.
    Tsai HW; Wang PH; Huang BS; Twu NF; Yen MS; Chen YJ
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):55-9. PubMed ID: 26927249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of LHRH analogues in gynaecology: a review.
    McLachlan RI; Healy DL; Burger HG
    Br J Obstet Gynaecol; 1986 May; 93(5):431-54. PubMed ID: 3085705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.